Why Shares of Avadel Are Sinking Today

Shares of Avadel Pharmaceuticals (NASDAQ: AVDL) are down 14% as of 1:29 p.m. EDT today after the Food and Drug Administration said it would need more time than originally thought to review FT218 -- Avadel's candidate to treat narcolepsy. 

After accepting a company's approval filing, the FDA provides applicants with a date known as the Prescription Drug User Fee Amendments date -- or PDUFA date. It's intended to give drugmakers insight into the review timeline.

Image source: Getty Images.

Continue reading

Source Fool.com